CAN
BHVN

Cetera Advisor Networks’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Cetera Advisor Networks’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,018
Closed -$456K – 2639
2022
Q3 		$456K Sell
3,018
-12
-0.4% -$1.78K 0.01% 1346
2022
Q2 		$442K Buy
3,030
+226
+8% +$28.9K 0.01% 1348
2022
Q1 		$332K Buy
+2,804
New +$350K ﹤0.01% 1570
2020
Q3 		– Sell
-1,530
Closed -$112K – 3496
2020
Q2 		$112K Buy
+1,530
New +$81.4K ﹤0.01% 1437

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Cetera Advisor Networks's BHVN Position: Q4 2022 in Review

Cetera Advisor Networks sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 3,018 shares — an estimated $456K sold.

Cetera Advisor Networks first reported a position in BHVN in Q2 2020 and held it in 4 quarters. The position peaked at $456K in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Cetera Advisor Networks reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Cetera Advisor Networks sold 3,018 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $456K.
  • Cetera Advisor Networks first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 4 quarters.
  • Cetera Advisor Networks's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $456K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Cetera Advisor Networks's 13F filing for Q4 2022, filed 14 Feb 2023.